NSE · JLHL
Jupiter Life Line Hospitals Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹365 Cr with net profit ₹51 Cr — a 14.11% net margin, versus 11.32% the period before.
Shareholding
As of 2026-09-30
- Promoter40.91%
- Public30.83%
- FII9.13%
- DII19.13%
33,255 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 6.96× from low to high.
Risk flags
Derived from disclosed data
- 52-week range spans 6.96× (₹233.4 to ₹1625) — an unusually wide band.
Peer comparison
Healthcare · ranked #19 of 86 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,13,611 Cr | 54 | 11.98 | 20.48% | 7.91% |
| Manipal Health Enterpri Limited | ₹86,401 Cr | 92.12 | 5.26 | 10.59% | 7.81% |
| Max Healthcare Institute Ltd. | ₹83,296 Cr | 55.64 | 7.75 | 13.42% | 16.73% |
| Aster DM Quality Care Ltd. | ₹58,441 Cr | 150.66 | 13.89 | 8.48% | 6.54% |
| Fortis Healthcare Ltd. | ₹55,965 Cr | 52.46 | 5.66 | 10.53% | 11.02% |
| Narayana Hrudayalaya Ltd. | ₹34,884 Cr | 40.47 | 7.69 | 17.76% | 9% |
| Global Health Limited | ₹33,959 Cr | 59.32 | 8.57 | 14.05% | 11.88% |
| Dr. Lal Path Labs Ltd. | ₹31,863 Cr | 56.65 | 12.7 | 20.13% | 18.75% |
| Krishna Institute of Medical Sciences Ltd. | ₹29,098 Cr | 139.4 | 7.76 | 10.74% | 4.85% |
| Dr. Agarwal's Health Care Limited | ₹15,179 Cr | 102.96 | 7.5 | 6.58% | 6.72% |
| Jupiter Life Line Hospitals Ltd.(this company) | ₹8,491 Cr | 44.73 | 5.21 | 11.43% | 11.5% |
AI analysis
AI-generated · google/gemini-2.5-flashJupiter Life Line Hospitals Ltd. has a market capitalization of Rs 10182 Cr. The company reported revenue of Rs 1290.22 Cr and an EPS of Rs 29.51. The Book Value per share is Rs 206.85.
Positives
- +The debt-to-equity ratio of 0.16 is low, indicating a healthy financial structure.
- +Promoter holding of 40.9139% as of June 2026 demonstrates significant insider commitment.
- +The company has no pledged promoter shares, standing at 0%.
Negatives
- −Public shareholding increased from 33.2997% in December 2024 to 33.2057% in June 2026.
- −FII holding decreased from 10.0419% in December 2024 to 9.3681% in June 2026.
- −The number of shareholders increased from 33914 in December 2024 to 33194 in June 2026, indicating a slight decrease.
Financial Performance
For the year ending March 2026, Jupiter Life Line Hospitals Ltd. reported a revenue of Rs 1542.155 Cr. The net profit for the same period was Rs 194.006 Cr. EBITDA stood at Rs 297.986 Cr for the year ending March 2026.
Profitability & Returns
The company's Return on Equity (ROE) is 15.3%, and Return on Capital Employed (ROCE) is 13.7714%. The Earnings Per Share (EPS) for the latest available annual period is Rs 29.51.
Balance Sheet
Jupiter Life Line Hospitals Ltd. has a debt-to-equity ratio of 0.16, indicating a low reliance on debt financing. The book value per share is Rs 206.85.
Ownership & Pledges
As of June 2026, promoter holding in Jupiter Life Line Hospitals Ltd. is 40.9139%. Public shareholding stands at 33.2057%. There are no pledged promoter shares.
Quarterly Performance
In the quarter ending March 2026, the company recorded revenue of Rs 387.84 Cr and a net profit of Rs 50.21 Cr. EBITDA for the same quarter was Rs 75.06 Cr. For the quarter ending December 2025, revenue was Rs 365.37 Cr with a net profit of Rs 42.55 Cr.
Data as of — price: 2026-10-27 · financials: Sep 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Jupiter Life Line Hospitals Ltd.share price & fundamentals